Latest News and Blogs

A ten-year cohort collaborative study was recently published, examining trends in fetal genetic testing and the use of new molecular genetic technologies.

Congenica launches an update that will provide automated classification, evidence and reporting of recurrent ‘known’ variants, significantly saving time.

What have we learnt in the months since the COVID-19 outbreak was reported? Are there specific genetic factors that influence susceptibility to infection?

40 leaders from the public and private sectors concluded that precision medicine's key barriers exist in policy and governance, not science and technology.

Sequencing and analysis of whole genomes in the 100,000 Genome Project led to the genetic diagnosis for 60% of patients with rare diseases.

Following a rigorous evaluation, Congenica was selected as the exclusive clinical decision support provider for the UK Genomic Medicine Service.

In this post, Suzanne Drury, PhD; Clinical Genomics and Personalized Medicine Specialist reviews prenatal diagnosis in the era of genomic medicine.

Congenica launches Congenica Prenatal, a new application that facilitate faster, more accurate and comprehensive molecular research into fetal anomalies.

This lightning talk highlights the background and findings from a recent study on the diagnosis of fetal structural abnormalities using exome sequencing.

Louisa Ive presents work on the use of exome sequencing in the diagnosis of fetal structural anomalies, highlighting its importance in a prenatal setting.

Genomics England has announced a major new sequencing project to uncover how a person’s genetic make-up influences their susceptibility to COVID-19.

With case loads increasing every day, clinical teams are experiencing increasing pressure to make their variant interpretation more efficient.